1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 18 MAY 2015

CNS Drug News 18 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - J&J's Invega Franchise Will Remain A Blockbuster
Industry Brief - Zambon Launches Xadago For Mid- To Late-Stage PD In Germany
Industry Brief - FDA Lifts Clinical Hold On NeuroDerm's SC Delivered Levodopa/Carbidopa For PD
Industry Trend Analysis - Hot Topics In MS: Progressive Disease And Remyelination
Industry Brief - Retrophin's RE-024 Receives FDA ODD For PKAN
Industry Brief - THR-18 Reduces ICH/Brain Oedema And Enhances Recovery In AIS Patients
Industry Brief - SDP/Takeda To Terminate Agreement For Latuda In Europe
Industry Brief - FDA Issues CRL To sNDA Seeking To Expand Invega Sustenna's Label
Industry Brief - Indivior Reports Positive Top-Line Results From RBP-7000 Phase III Trial In Schizophrenia
Industry Brief - Curemark Launches Phase III Trial In Expanded Population Of Children With Autism
Industry Brief - Pernix Launches Zohydro ER With BeadTek
Industry Brief - FDA Approves Treximet For Use In Paediatric Patients
Industry Brief - Teva Presents Further Data From Phase IIb With TEV-48125 In Chronic Migraine
Industry Brief - Amgen's AMG 334 Phase II Study In Episodic Migraine Prevention Meets Primary Endpoint
Industry Brief - Adynxx Completes Enrolment In AYX1 Phase II Study For Post-Surgical Pain Prevention
Industry Brief - US Patent Allowed Covering Relmada's Securel Abuse-Deterrent Technology Platform
Industry Brief - Fycompa Launched In Italy
Industry Brief - GW Initiates Phase II Study Of CBDV In Epilepsy
Industry Brief - SAGE Achieves 77% Response Rate In Completed Phase I/II Trial In SRSE
Industry Brief - GW Initiates Phase III Pivotal Study Of Epidiolex In LGS
Industry Trend Analysis - Orexigen's Shares Slump But Contrave Sales Will Not Follow Suit
Industry Brief - TGA Approves Akynzeo For CINV Prevention
Industry Brief - Acacia Reports Positive Results From Phase II Study With APD403 In CINV
Industry Brief - Arena/Roivant Enter Collaboration For Nelotanserin
Industry Trend Analysis - Lundbeck's Revenue To Remain Stable In 2015
Industry Brief - Teva Completes Acquisition Of Auspex Pharmaceuticals
Industry Brief - GW Closes US Public Offering Raising Approximately USD179.2mn
Industry Brief - Newron Raises Funds To Accelerate Development Of Novel Medicines For Rare CNS Disorders
Industry Brief - CNS Conferences - August 2015

Table Of Contents

CNS Drug News 18 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.